YAP1 (S6A) - V5 in pLX304 Citations (9)
Originally described in: beta-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis.Rosenbluh J, Nijhawan D, Cox AG, Li X, Neal JT, Schafer EJ, Zack TI, Wang X, Tsherniak A, Schinzel AC, Shao DD, Schumacher SE, Weir BA, Vazquez F, Cowley GS, Root DE, Mesirov JP, Beroukhim R, Kuo CJ, Goessling W, Hahn WC Cell. 2012 Dec 21;151(7):1457-73. doi: 10.1016/j.cell.2012.11.026. Epub 2012 Dec 13. PubMed Journal
Articles Citing YAP1 (S6A) - V5 in pLX304
Articles |
---|
Hippo pathway mediates resistance to cytotoxic drugs. Gujral TS, Kirschner MW. Proc Natl Acad Sci U S A. 2017 May 2;114(18):E3729-E3738. doi: 10.1073/pnas.1703096114. Epub 2017 Apr 17. PubMed |
YAP1-Mediated Suppression of USP31 Enhances NFkappaB Activity to Promote Sarcomagenesis. Ye S, Lawlor MA, Rivera-Reyes A, Egolf S, Chor S, Pak K, Ciotti GE, Lee AC, Marino GE, Shah J, Niedzwicki D, Weber K, Park PMC, Alam MZ, Grazioli A, Haldar M, Xu M, Perry JA, Qi J, Eisinger-Mathason TSK. Cancer Res. 2018 May 15;78(10):2705-2720. doi: 10.1158/0008-5472.CAN-17-4052. Epub 2018 Feb 28. PubMed |
YAP inhibition enhances the differentiation of functional stem cell-derived insulin-producing beta cells. Rosado-Olivieri EA, Anderson K, Kenty JH, Melton DA. Nat Commun. 2019 Apr 1;10(1):1464. doi: 10.1038/s41467-019-09404-6. PubMed |
The mitochondrial deoxyguanosine kinase is required for cancer cell stemness in lung adenocarcinoma. Lin S, Huang C, Sun J, Bollt O, Wang X, Martine E, Kang J, Taylor MD, Fang B, Singh PK, Koomen J, Hao J, Yang S. EMBO Mol Med. 2019 Oct 21:e10849. doi: 10.15252/emmm.201910849. PubMed |
Fascin promotes lung cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression. Lin S, Li Y, Wang D, Huang C, Marino D, Bollt O, Wu C, Taylor MD, Li W, DeNicola GM, Hao J, Singh PK, Yang S. Cancer Lett. 2021 Oct 10;518:230-242. doi: 10.1016/j.canlet.2021.07.025. Epub 2021 Jul 22. PubMed |
Viral Manipulation of a Mechanoresponsive Signaling Axis Disassembles Processing Bodies. Castle EL, Robinson CA, Douglas P, Rinker KD, Corcoran JA. Mol Cell Biol. 2021 Oct 26;41(11):e0039921. doi: 10.1128/MCB.00399-21. Epub 2021 Sep 13. PubMed |
Disruption of pancreatic stellate cell myofibroblast phenotype promotes pancreatic tumor invasion. Murray ER, Menezes S, Henry JC, Williams JL, Alba-Castellon L, Baskaran P, Quetier I, Desai A, Marshall JJT, Rosewell I, Tatari M, Rajeeve V, Khan F, Wang J, Kotantaki P, Tyler EJ, Singh N, Reader CS, Carter EP, Hodivala-Dilke K, Grose RP, Kocher HM, Gavara N, Pearce O, Cutillas P, Marshall JF, Cameron AJM. Cell Rep. 2022 Jan 25;38(4):110227. doi: 10.1016/j.celrep.2021.110227. PubMed |
Multicellular aligned bands disrupt global collective cell behavior. Jebeli M, Lopez SK, Goldblatt ZE, McCollum D, Mana-Capelli S, Wen Q, Billiar K. Acta Biomater. 2022 Oct 26:S1742-7061(22)00698-5. doi: 10.1016/j.actbio.2022.10.041. PubMed |
Targeting ABCA12-controlled ceramide homeostasis inhibits breast cancer stem cell function and chemoresistance. Cui J, Christin JR, Reisz JA, Cendali FI, Sanawar R, Coutinho De Miranda M, D'Alessandro A, Guo W. Sci Adv. 2023 Dec;9(48):eadh1891. doi: 10.1126/sciadv.adh1891. Epub 2023 Dec 1. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.